Guidelines promote high quality cancer care. Rehabilitation recommendations in oncology
guidelines have not been characterized and may provide insight to improve integration of …

Gastrointestinal stromal tumor (GIST) provides a paradigm to evaluate new molecularly
targeted therapies and to identify structural and functional mechanisms for drug response …

Background Pathological complete response to preoperative treatment in adults with soft-
tissue sarcoma can be achieved in only a few patients receiving radiotherapy. This phase 2 …

Background Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare
tumors of mesenchymal origin that include several well-defined histologic subtypes. In 2015 …

Background Among sarcomas, which are rare cancers, many types are exceedingly rare;
however, a definition of ultra‐rare cancers has not been established. The problem of ultra …

Gastrointestinal stromal tumors (GISTs) are potentially malignancies that can occur
anywhere in the digestive tract. Tyrosine kinase inhibitors (TKIs) such as imatinib have …

Background This study was aimed at determining whether patients with high-risk soft tissue
sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant …

Background The optimal treatment for advanced leiomyosarcoma is still debated. Given
histotype‐specific prospective controlled data lacking, this study retrospectively evaluated …

Although many studies have focused on oncology and therapeutics in cancer, cancer
remains one of the leading causes of death worldwide. Due to the unclear molecular …

Background Guidelines recommend that retroperitoneal sarcoma (RPS) be managed in a
reference sarcoma center (RSC), but the benefit remains to be demonstrated. This study …